NO20005103D0 - Nye cyanoindol serotonin-reopptaks-inhibitorforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem - Google Patents

Nye cyanoindol serotonin-reopptaks-inhibitorforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem

Info

Publication number
NO20005103D0
NO20005103D0 NO20005103A NO20005103A NO20005103D0 NO 20005103 D0 NO20005103 D0 NO 20005103D0 NO 20005103 A NO20005103 A NO 20005103A NO 20005103 A NO20005103 A NO 20005103A NO 20005103 D0 NO20005103 D0 NO 20005103D0
Authority
NO
Norway
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
cyanoindole
novel
Prior art date
Application number
NO20005103A
Other languages
English (en)
Other versions
NO321242B1 (no
NO20005103L (no
Inventor
Gilbert Lavielle
Olivier Muller
Mark Millan
Didier Cussac
Anne Dekeyne
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO20005103D0 publication Critical patent/NO20005103D0/no
Publication of NO20005103L publication Critical patent/NO20005103L/no
Publication of NO321242B1 publication Critical patent/NO321242B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20005103A 1999-10-12 2000-10-10 Nye cyanoindol serotonin-reopptaks-inhibitorforbindelser, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem NO321242B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9912668A FR2799463B1 (fr) 1999-10-12 1999-10-12 Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et ces compositions pharmaceutiques qui les contiennent

Publications (3)

Publication Number Publication Date
NO20005103D0 true NO20005103D0 (no) 2000-10-10
NO20005103L NO20005103L (no) 2001-04-17
NO321242B1 NO321242B1 (no) 2006-04-10

Family

ID=9550799

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005103A NO321242B1 (no) 1999-10-12 2000-10-10 Nye cyanoindol serotonin-reopptaks-inhibitorforbindelser, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem

Country Status (23)

Country Link
US (1) US6492366B1 (no)
EP (1) EP1092715B1 (no)
JP (1) JP3274454B2 (no)
KR (1) KR100470692B1 (no)
CN (1) CN1146568C (no)
AT (1) ATE291577T1 (no)
AU (1) AU774741B2 (no)
BR (1) BR0004764A (no)
CA (1) CA2323703C (no)
DE (1) DE60018869T2 (no)
DK (1) DK1092715T3 (no)
EA (1) EA003831B1 (no)
ES (1) ES2238260T3 (no)
FR (1) FR2799463B1 (no)
HK (1) HK1036062A1 (no)
HU (1) HUP0003991A2 (no)
MX (1) MXPA00009642A (no)
NO (1) NO321242B1 (no)
NZ (1) NZ507458A (no)
PL (1) PL343148A1 (no)
PT (1) PT1092715E (no)
SI (1) SI1092715T1 (no)
ZA (1) ZA200005625B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6693202B1 (en) 1999-02-16 2004-02-17 Theravance, Inc. Muscarinic receptor antagonists
US6559169B2 (en) 2001-04-24 2003-05-06 Wyeth Antidepressant azaheterocyclymethyl derivatives of 2,3-dihydro-1,4-benzodioxan
US7041683B2 (en) 2001-04-24 2006-05-09 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1, 4-benzodiozan
US7276603B2 (en) * 2003-05-02 2007-10-02 Wyeth Benzofuranyl-and benzothienyl-piperazinyl quinolines and methods of their use
WO2005113833A2 (en) * 2004-05-21 2005-12-01 Duke University Polymorphism in tryptophan hydroxylase-2 controls brain serotonin synthesis
WO2012054815A1 (en) 2010-10-22 2012-04-26 Duke University Slow-release formulations of 5-hydroxytryptophan as an adjunct to pro-serotonergic therapies

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2043709C (en) * 1990-06-29 2002-01-22 David W. Smith Antimigraine alkoxypyrimidine derivatives
HUT64326A (en) * 1990-10-15 1993-12-28 Pfizer Process for production indole derivatives and pharmaceutical preparations containing these compounds
GB9208161D0 (en) * 1992-04-14 1992-05-27 Pfizer Ltd Indoles
FR2701026B1 (fr) * 1993-02-02 1995-03-31 Adir Nouveaux dérivés de l'indole, de l'indazole et du benzisoxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
IT1271352B (it) * 1993-04-08 1997-05-27 Boehringer Ingelheim Italia Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale
ES2079323B1 (es) * 1994-06-21 1996-10-16 Vita Invest Sa Derivados de indol utiles para el tratamiento de la migraña, composicion y uso correspondientes.
AU2809295A (en) * 1994-07-11 1996-02-09 Dsm N.V. Multihydroxy-functional oligophenylene oxide
AR004229A1 (es) * 1995-11-06 1998-11-04 Wyeth Corp Derivados indolalquilo de benzodioxanmetilamina y su uso para preparar medicamentos
US5912256A (en) * 1996-06-20 1999-06-15 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5998462A (en) * 1996-12-16 1999-12-07 Allelix Biopharmaceuticals Inc. 5-alkyl indole compounds

Also Published As

Publication number Publication date
BR0004764A (pt) 2001-05-29
DE60018869T2 (de) 2006-02-02
ES2238260T3 (es) 2005-09-01
JP3274454B2 (ja) 2002-04-15
EA200000929A3 (ru) 2001-06-25
KR100470692B1 (ko) 2005-03-07
HK1036062A1 (en) 2001-12-21
JP2001151772A (ja) 2001-06-05
MXPA00009642A (es) 2002-05-23
CA2323703A1 (fr) 2001-04-12
FR2799463A1 (fr) 2001-04-13
CN1146568C (zh) 2004-04-21
HUP0003991A2 (en) 2002-06-29
PT1092715E (pt) 2005-06-30
DK1092715T3 (da) 2005-07-25
ATE291577T1 (de) 2005-04-15
AU774741B2 (en) 2004-07-08
EA003831B1 (ru) 2003-10-30
ZA200005625B (en) 2001-05-02
HU0003991D0 (en) 2000-12-28
US6492366B1 (en) 2002-12-10
EA200000929A2 (ru) 2001-04-23
KR20010050984A (ko) 2001-06-25
FR2799463B1 (fr) 2004-04-16
CA2323703C (fr) 2005-08-16
EP1092715A3 (fr) 2001-08-08
NZ507458A (en) 2002-03-28
NO321242B1 (no) 2006-04-10
SI1092715T1 (en) 2005-06-30
AU6547900A (en) 2001-04-26
PL343148A1 (en) 2001-04-23
NO20005103L (no) 2001-04-17
CN1296010A (zh) 2001-05-23
EP1092715B1 (fr) 2005-03-23
DE60018869D1 (de) 2005-04-28
EP1092715A2 (fr) 2001-04-18

Similar Documents

Publication Publication Date Title
AR058554A1 (es) Compuestos heterociclicos nitrogenados de 6 miembros sustituidos, metodos para su preparacion, composiciones farmaceuticas que los contienen y su uso en el tratamiento de enfermedades mediadas por mglur5.
AR064491A1 (es) Derivados de imidazo[1, 2-a]pirimidina, un proceso para su preparacion, una composicion farmaceutica que los comprende y su uso en el tratamiento de enfermedades mediadas por las quinasas fgfr.
AR025386A1 (es) Moduladores de los receptores activados del proliferador de peroxisomas
DK1295890T3 (da) Hidtil ukendte pyrazinderivater eller salte deraf, farmaceutiske præparater, der indeholder derivaterne eller saltene, og mellemprodukter til fremstilling af begge
AR063142A1 (es) Derivados de 2-(bencimidazolil) purina y purinonas 6-sustituidas utiles como inmunosupresores,y composiciones farmaceuticas que los contienen.
AR023152A1 (es) Compuesto tienopirimidina, procedimiento para producirlo, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar dichacomposicion
ES549542A0 (es) Un procedimiento para preparar nuevos derivados de benzo- triazol- y benzoxazolamina
AR037907A1 (es) Derivados de azaindolilalquilamina como ligandos de 5-hidroxitriptamina-6
AR061615A1 (es) Moduladores de receptores metabotropicos de glutamato
DK0521827T3 (da) Farmakologisk virksomme hydrazinderivater og fremgangsmåde til deres fremstilling
AR050153A1 (es) Beta-agonistas, procedimiento para su preparacion y su uso como medicamentos
NO20005103D0 (no) Nye cyanoindol serotonin-reopptaks-inhibitorforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem
AR030698A1 (es) 1-aril-4-oxo-1,4-dihidro-3-quinolincarboxamidas,, una composicion farmaceutica, uso de los mismos para preparar un medicamento como agentes antivirales y un metodo para inhibir una adn polimerasa viral
AR038842A1 (es) Derivados de artemisinina (endoperoxidos) antiparasitarios
AR026222A1 (es) Compuestos derivados de acido antranilico
MXPA04005837A (es) Nuevos derivados de benzotiazina y benzotiadiazina, metodo para su preparacion y composiciones farmaceuticas que los contienen.
DK1101765T3 (da) Camptothecin-analoge forbindelser, fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger, der indeholder dem
CO5180536A1 (es) Inhibidores de proteasas catepsina
DK0812838T3 (da) Pyridoncarboxylsyrederivater substitueret med bicyclisk aminogruppe, estere og salte deraf og bicyclisk amin som mellemprodukt
AR031438A1 (es) Ciclohexil(alquil)-propanolaminas, su preparacion y composiciones farmaceuticas que las contienen
DK1010698T3 (da) Hidtil ukendte derivater af 1,2-dithiolan, fremgangsmåde til fremstiling deraf og farmaceutiske sammensætninger indeholdende dem
NO20002940L (no) Nye forbindelser av 7-okso-2,3,7,14-tetrahydro-1H-benzo- [b]pyrano[3,2-h]akridinkarboksylat, en fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
NO20002315D0 (no) Nye 1-aza-2-alkyl-6-aryl-cykloalkanforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem
DK0820985T3 (da) Bis-imidderivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende dem
DK0911336T3 (da) Pyridoncarboxylsyrederivater og mellemprodukter til deres fremstilling